$GENI stock fell 18% this week, according to our price data from Polygon.
It has been the 25th most-searched ticker on Quiver Quantitative over the last week, out of 50 total tickers searched.
Here is what we see in our data on $GENI (you can track the company live on Quiver's $GENI stock page):
$GENI Insider Trading Activity
$GENI insiders have traded $GENI stock on the open market 4 times in the past 6 months. Of those trades, 0 have been purchases and 4 have been sales.
Here’s a breakdown of recent trading of $GENI stock by insiders over the last 6 months:
- MARK LOCKE (Chief Executive Officer) has made 0 purchases and 3 sales selling 800,000 shares for an estimated $5,255,567.
- THOMAS RUSSELL (Chief Legal Officer) sold 50,000 shares for an estimated $325,565
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
$GENI Hedge Fund Activity
We have seen 181 institutional investors add shares of $GENI stock to their portfolio, and 163 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- VOSS CAPITAL, LP removed 6,225,000 shares (-47.6%) from their portfolio in Q2 2026, for an estimated $37,723,500
- TIMESSQUARE CAPITAL MANAGEMENT, LLC removed 5,782,631 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $35,042,743
- HOOD RIVER CAPITAL MANAGEMENT LLC added 5,686,089 shares (+78.5%) to their portfolio in Q2 2026, for an estimated $34,457,699
- BLACKROCK, INC. added 5,138,884 shares (+35.1%) to their portfolio in Q2 2026, for an estimated $31,141,637
- GLENVIEW CAPITAL MANAGEMENT, LLC added 4,934,399 shares (+57.6%) to their portfolio in Q2 2026, for an estimated $29,902,457
- FRONTIER CAPITAL MANAGEMENT CO LLC added 4,464,966 shares (+89.9%) to their portfolio in Q2 2026, for an estimated $27,057,693
- PORTOLAN CAPITAL MANAGEMENT, LLC added 4,234,791 shares (+151.7%) to their portfolio in Q2 2026, for an estimated $25,662,833
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
$GENI Analyst Ratings
Wall Street analysts have issued reports on $GENI in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Needham issued a "Buy" rating on 05/08/2026
To track analyst ratings and price targets for $GENI, check out Quiver Quantitative's $GENI forecast page.
$GENI Price Targets
Multiple analysts have issued price targets for $GENI recently. We have seen 5 analysts offer price targets for $GENI in the last 6 months, with a median target of $9.0.
Here are some recent targets:
- Bernie McTernan from Needham set a target price of $10.0 on 05/08/2026
- Jason Bazinet from Citigroup set a target price of $8.0 on 05/08/2026
- Clark Lampen from BTIG set a target price of $9.0 on 05/07/2026
- Barry Jonas from Truist Securities set a target price of $10.0 on 04/21/2026
- Jeffrey Stantial from Stifel set a target price of $5.0 on 04/09/2026
You can track data on $GENI on Quiver Quantitative.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
